TCRT

$1.86+6.29%visit website

Alaunos Therapeutics, Inc.

Market Cap

$5M

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-1.03

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

1575.1

TTM to Jun 2026 · revenue

P/B

7.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	3.00	0.00	0.00	3.00
Research & development	469	361	427	388	1,645
Total operating expenses	1,187	910	1,012	952	4,061
Operating income	(1,187)	(907)	(1,012)	(952)	(4,058)
Net income	(1,159)	(893)	(1,006)	(952)	(4,010)
EPS (basic) ($)	(0.55)		(0.59)	(0.41)	(1.75)
EPS (diluted) ($)	(0.55)		(0.59)	(0.41)	(1.75)
Weighted avg. shares (basic)	2,183		1,948	2,432
Weighted avg. shares (diluted)	2,183		1,948	2,432

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 63 more quarters, back to Sep 2009, with Tormere Pro.

Corporate Events (8-K)

13 filings in 12 months · 4 with priority itemsFull history →

Filed	Items	Filing
Oct 23, 2026 accepted 4:30 PM ET	8.01Other events	Document SEC ↗
Oct 21, 2026 accepted 4:30 PM ET	3.01Delisting notice	Document SEC ↗
Oct 13, 2026 accepted 9:28 AM ET	1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale5.02Officer / director change5.03Bylaws / fiscal year7.01Reg FD disclosure	Document SEC ↗
Oct 9, 2026 accepted 4:30 PM ET	3.01Delisting notice	Document SEC ↗
Sep 22, 2026 accepted 4:30 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Sep 17, 2026 accepted 9:03 PM ET	3.03Holder rights modified5.03Bylaws / fiscal year	Document SEC ↗
Jun 29, 2026 accepted 8:30 AM ET	8.01Other events	Document SEC ↗
May 26, 2026 accepted 11:00 AM ET	8.01Other events	Document SEC ↗
May 18, 2026 accepted 8:00 AM ET	8.01Other events	Document SEC ↗
Apr 15, 2026 accepted 4:32 PM ET	3.01Delisting notice	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

62%

W/W -4.9pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · 2026-10-23

Unusual Volume Standouts in the Latest Session

ChartMill · 2026-10-19

Premarket Movers Oct. 19: Disc Medicine Jumps 51.62%, Rubico Falls 33.84%

ChartMill · 2026-10-19

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga · 2026-10-19

Unusual Volume Movers: WFF, TGL, XXII and HODO Among US-Listed Stocks in Heavy Trading

ChartMill · 2026-10-16

US Gap-Up and Gap-Down Stocks in the October 16, 2026 Session

ChartMill · 2026-10-16

These stocks that are showing activity before the opening bell on Friday.

ChartMill · 2026-10-16

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 2026-10-16

TCRT Stock Explodes As Alaunos Lands $350M Velaris Deal

Timothy Sykes · 2026-10-16

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-16

Thursday's after hours session: top gainers and losers

ChartMill · 2026-10-15

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga · 2026-10-15

Two 9.99% holders agree to back merger votes in Alaunos (TCRT)'s conditional repurchase deal.

Stock Titan · 2026-10-15

Let's take a look at the stocks that are in motion in today's session.

ChartMill · 2026-10-14

TCRT Stock Explodes After Velaris Deal And $350M Raise

StocksToTrade · 2026-10-14

Informational purposes only, not investment advice.

Corporate Events (8-K)

13 filings in 12 months · 4 with priority itemsFull history →

Filed	Items	Filing
Oct 23, 2026 accepted 4:30 PM ET	8.01Other events	Document SEC ↗
Oct 21, 2026 accepted 4:30 PM ET	3.01Delisting notice	Document SEC ↗
Oct 13, 2026 accepted 9:28 AM ET	1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale5.02Officer / director change5.03Bylaws / fiscal year7.01Reg FD disclosure	Document SEC ↗
Oct 9, 2026 accepted 4:30 PM ET	3.01Delisting notice	Document SEC ↗
Sep 22, 2026 accepted 4:30 PM ET	1.01Material agreement8.01Other events	Document SEC ↗
Sep 17, 2026 accepted 9:03 PM ET	3.03Holder rights modified5.03Bylaws / fiscal year	Document SEC ↗
Jun 29, 2026 accepted 8:30 AM ET	8.01Other events	Document SEC ↗
May 26, 2026 accepted 11:00 AM ET	8.01Other events	Document SEC ↗
May 18, 2026 accepted 8:00 AM ET	8.01Other events	Document SEC ↗
Apr 15, 2026 accepted 4:32 PM ET	3.01Delisting notice	Document SEC ↗

TCRT

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Alaunos Therapeutics, Inc. (TCRT)

Factor Profile

Corporate Events (8-K)